Low serum free testosterone is independently associated with sarcopenic obesity in males with type 2 diabetes: a post hoc cross-sectional analysis from the impact of diabetes mellitus on dynapenia study.
文献摘要
Aims Testosterone plays a key role in maintaining skeletal muscle mass, strength, and overall physical function, while also preventing excess fat accumulation. However, limited evidence focusing specifically on free testosterone and sarcopenic obesity in males with type 2 diabetes (T2D) is available. This study aimed to investigate the association between serum free testosterone and sarcopenic obesity in males with T2D according to the newly established Japanese consensus definition. Methods This post hoc cross-sectional analysis used data from the multicenter, cross-sectional Impact of Diabetes Mellitus on Dynapenia study. Sarcopenic obesity was defined based on the Japanese Working Group on Sarcopenic Obesity criteria as the combination of a high body mass index (BMI) or waist circumference with low grip strength, high body fat percentage, and low appendicular skeletal muscle mass adjusted for BMI. Serum free testosterone was measured, and multivariate logistic regression analysis was used to evaluate the association with sarcopenic obesity. Results Males with sarcopenic obesity had significantly lower serum free testosterone than those without sarcopenic obesity ( p =0.002). Multivariate analysis identified low free testosterone ( p =0.003) as an independent correlate of sarcopenic obesity. Conclusions Low serum free testosterone is independently associated with sarcopenic obesity in males with T2D. Supplementary information The online version contains supplementary material available at https://doi.org/10.1007/s13340-026-00929-y.